Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Gait & Posture
|
October 5, 2013
Ellipse area calculations and their applicability in posturography
Patric Schubert, Marietta Kirchner
Biometrical Journal. Biometrische Zeitschrift
|
October 8, 2019
Adjustment for exploratory cut-off selection in randomized clinical trials with survival endpoint
Heiko Götte, Marietta Kirchner, Meinhard Kieser
Biometrical Journal. Biometrische Zeitschrift
|
September 6, 2018
Optimal sample size allocation and go/no-go decision rules for phase II/III programs where several phase III trials are performed
Stella Preussler, Meinhard Kieser, Marietta Kirchner
Journal of Biopharmaceutical Statistics
|
June 13, 2025
Estimation of treatment effects in early phase randomized clinical trials involving multiple data sources for external control
Heiko Götte, Marietta Kirchner, Meinhard Kieser
Pharmaceutical Statistics
|
March 12, 2024
Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints
Marietta Kirchner, Stefanie Schüpke, Meinhard Kieser
Journal of Biopharmaceutical Statistics
|
April 24, 2026
Estimation, testing and sample size calculation within the responder-stratified exponential survival model
Samuel Kilian, Marietta Kirchner, Meinhard Kieser
Pharmaceutical Statistics
|
February 24, 2017
Probability of success for phase III after exploratory biomarker analysis in phase II
Heiko Götte, Marietta Kirchner, Martin Oliver Sailer
Statistics in Medicine
|
August 11, 2015
Utility-based optimization of phase II/III programs
Marietta Kirchner, Meinhard Kieser, Heiko Götte, et al.
BMC Medical Research Methodology
|
October 10, 2020
Optimal designs for phase II/III drug development programs including methods for discounting of phase II results
Stella Erdmann, Marietta Kirchner, Heiko Götte, et al.
Pharmaceutical Statistics
|
April 28, 2018
Optimal planning of phase II/III programs for clinical trials with multiple endpoints
Meinhard Kieser, Marietta Kirchner, Eva Dölger, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Gait & Posture
|
October 5, 2013
Ellipse area calculations and their applicability in posturography
Patric Schubert, Marietta Kirchner
Biometrical Journal. Biometrische Zeitschrift
|
October 8, 2019
Adjustment for exploratory cut-off selection in randomized clinical trials with survival endpoint
Heiko Götte, Marietta Kirchner, Meinhard Kieser
Biometrical Journal. Biometrische Zeitschrift
|
September 6, 2018
Optimal sample size allocation and go/no-go decision rules for phase II/III programs where several phase III trials are performed
Stella Preussler, Meinhard Kieser, Marietta Kirchner
Journal of Biopharmaceutical Statistics
|
June 13, 2025
Estimation of treatment effects in early phase randomized clinical trials involving multiple data sources for external control
Heiko Götte, Marietta Kirchner, Meinhard Kieser
Pharmaceutical Statistics
|
March 12, 2024
Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints
Marietta Kirchner, Stefanie Schüpke, Meinhard Kieser
Journal of Biopharmaceutical Statistics
|
April 24, 2026
Estimation, testing and sample size calculation within the responder-stratified exponential survival model
Samuel Kilian, Marietta Kirchner, Meinhard Kieser
Pharmaceutical Statistics
|
February 24, 2017
Probability of success for phase III after exploratory biomarker analysis in phase II
Heiko Götte, Marietta Kirchner, Martin Oliver Sailer
Statistics in Medicine
|
August 11, 2015
Utility-based optimization of phase II/III programs
Marietta Kirchner, Meinhard Kieser, Heiko Götte, et al.
BMC Medical Research Methodology
|
October 10, 2020
Optimal designs for phase II/III drug development programs including methods for discounting of phase II results
Stella Erdmann, Marietta Kirchner, Heiko Götte, et al.
Pharmaceutical Statistics
|
April 28, 2018
Optimal planning of phase II/III programs for clinical trials with multiple endpoints
Meinhard Kieser, Marietta Kirchner, Eva Dölger, et al.
Page
of 8